Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Fluid Resuscitation Optimization in Surgical Trauma Patients (FROST)

NCT: NCT02742974 · TERMINATED

NCT IDNCT02742974
StatusTERMINATED
Start Date2015-10
Completion2017-11
SponsorCAMC Health System (OTHER)
First posted
Last updated

Brief Summary

The aim of this study is to determine if the incidence of post-operative complications can be decreased by the implementation of intra-operative, minimally invasive hemodynamic monitoring (MIHM) via FloTrac™ and EV1000™ in trauma patients.

Frequently Asked Questions

What is Fluid Resuscitation Optimization in Surgical Trauma Patients (FROST)?

Fluid Resuscitation Optimization in Surgical Trauma Patients (FROST) is a clinical trial registered under NCT02742974. Current status: TERMINATED.

What is the status of NCT02742974?

The current status of NCT02742974 (Fluid Resuscitation Optimization in Surgical Trauma Patients (FROST)) is: TERMINATED.

When did Fluid Resuscitation Optimization in Surgical Trauma Patients (FROST) start?

Fluid Resuscitation Optimization in Surgical Trauma Patients (FROST) started on 2015-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑